ReviewFrontiers in pharmacology2026
Tibetan medicine Baxiaga: a systematic review of its historical herbalogical investigation, phytochemical constituents, and pharmacological activities.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Baxiaga (བ་ཤ་ཀ) is a typical Tibetan medicinal species of multiple origin. These plants have been used in traditional Tibetan medicine for centuries and are currently used to treat various types of fever, such as Chiba fever, liver fever, reduce inflammation, relieve pain, and heal other diseases. Objective: This review aims to provide a comprehensive analysis of the traditional uses of the baxiaga series of plants ( Materials and Methods: This review performed an extensive database search to collect detailed information about baxiaga and the literature was systematically interpreted, analyzed, and documented. Results: This review summarizes the traditional usage of five plants in Tibetan medicine baxiaga, which includes 195 chemical constituents such as alkaloids, flavonoids, terpenoids, and iridoid glycosides. This research elaborates on the pharmacological activities and mechanisms of these medicinal plants, along with discussions on multi-origin and quality control issues, while also proposing future research directions. Conclusion: This study presents a comprehensive analysis of the five medicinal plants commonly used in baxiaga. Our analysis highlights the significant value of baxiaga as an ethnomedicinal resource and reveals that its pharmacological activity is mainly attributed to its alkaloid. These alkaloids demonstrate anti-inflammatory, antioxidant and hepatoprotective, activities. However, current studies on the medicinal effects, active ingredient content, quality control, and clinical applications of baxiaga have limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.